HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mary K G McStay Selected Research

yttrium 90-DOTA-lanreotide

11/2005Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mary K G McStay Research Topics

Disease

1Liver Diseases (Liver Disease)
11/2005
1Neoplasm Metastasis (Metastasis)
11/2005
1Neoplasms (Cancer)
11/2005
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2005

Drug/Important Bio-Agent (IBA)

1lanreotide (Somatuline)FDA Link
11/2005
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2005
1pentetreotide (OctreoScan)FDA Link
11/2005
1yttrium 90-DOTA-lanreotideIBA
11/2005
1AcidsIBA
11/2005
1Biological ProductsIBA
11/2005
1IndiumIBA
11/2005
1YttriumIBA
11/2005
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2005

Therapy/Procedure

1Intra-Arterial Injections
11/2005
1Palliative Care (Palliative Therapy)
11/2005